DCGI approves Regenerative Medical’s stem cell therapy for cartilage defects1 min read . Updated: 12 Apr 2017, 09:11 PM IST
Regenerative Medical Services said the DCGI recently approved its stem cell-based therapy Chondron to treat cartilage defects
Mumbai: Regenerative Medical Services Pvt. Ltd on Wednesday said that the Drug Controller General of India (DCGI) recently approved its stem cell-based therapy to treat cartilage defects.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more